Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the Northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing. MSK has ranked as one of the top two cancer hospitals in the U.S. and the best cancer center in the Northeast since these rankings were established more than 35 years ago.
“Being named as the best cancer center in the Northeast, and a top two hospital for cancer care in the nation is an honor,” said Selwyn M. Vickers, MD, FACS, President & CEO of MSK. “This recognition reminds us of MSK’s unique role in the history and future of cancer care and the obligation we have to patients. We are committed to providing world-class cancer care and pursuing breakthrough research to advance our mission of ending cancer for life.”
This year’s recognition as one of the nation’s best cancer hospitals comes as experts from across MSK have been honored for their groundbreaking contributions to cancer research, patient care, and education. Some of these achievements include a groundbreaking study demonstrating an MSK-pioneered treatment approach harnessing only immunotherapy to improve patients’ quality of life; the approval of 11 drugs by the U.S. Food and Drug Administration (FDA), based on clinical trials where MSK played a key role; the third time MSK nursing staff achieved designation by the American Nurses Credentialing Center (ANCC) Magnet Recognition Program®, the nation’s highest honor for excellence in nursing; increasing community access to cancer screening; transforming care with genomic-driven diagnosis and treatment; and shaping the future of cancer care through the development of cancer vaccines.
This is the third consecutive year MSK has been ranked as the number one hospital for urology care in the nation. The MSK’s urology service team is comprised of world-class specialists in surgery, medical oncology, chemotherapy, radiation oncology, radiology, pathology, and nursing, who collaborate to deliver the best treatment for each patient, focusing on innovation, care, and preserving quality of life.
MSK disease subspecialties, including gastroenterology & GI surgery (ranked #14), and ear, nose, and throat (ranked #25), were included on the publication’s top 50 list.
“MSK is the most advanced and innovative force against cancer in the world,” said Dr. Vickers. “We will continue to be dedicated to helping individuals with cancer live healthier, more fulfilling lives during and after treatment, ensuring they not only survive but thrive.”
The U.S. News & World Report rankings are determined using a broad set of factors. These include the hospital’s reputation among board-certified physician specialists, risk-adjusted mortality rates, preventable complications and level of nursing care, among other criteria. For a complete list and methodology of rankings, please visit U.S. News & World Report.
Contact:
Carolina Takacs
[email protected]